UK markets open in 3 hours 14 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,383.40 +176.27 (+0.97%) CRUDE OIL
79.12 +0.17 (+0.22%) GOLD FUTURES
2,309.70 +0.10 (+0.00%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,646.97 +1,908.16 (+4.17%)
Ovid Therapeutics Inc. (1OT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:12AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 203.15M |
| Enterprise value | 118.93M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 594.69 |
| Price/book (mrq) | 2.66 |
| Enterprise value/revenue | 303.62 |
| Enterprise value/EBITDA | -2.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.69 |
| 52-week change 3 | -0.65% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 3.6800 |
| 52-week low 3 | 2.4600 |
| 50-day moving average 3 | 2.9136 |
| 200-day moving average 3 | 3.1248 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 70.81M |
| Implied shares outstanding 6 | 77.24M |
| Float 8 | 37.59M |
| % held by insiders 1 | 15.97% |
| % held by institutions 1 | 64.68% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -13,978.47% |
Management effectiveness
| Return on assets (ttm) | -24.76% |
| Return on equity (ttm) | -47.57% |
Income statement
| Revenue (ttm) | 391.69k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | 205.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -58.71M |
| Net income avi to common (ttm) | -52.34M |
| Diluted EPS (ttm) | -0.6900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 105.83M |
| Total cash per share (mrq) | 1.5 |
| Total debt (mrq) | 16M |
| Total debt/equity (mrq) | 18.23% |
| Current ratio (mrq) | 9.55 |
| Book value per share (mrq) | 1.24 |
Cash flow statement
| Operating cash flow (ttm) | -45.78M |
| Levered free cash flow (ttm) | -25.92M |
© 2024 Yahoo. All rights reserved.